000			01587 a2200445 4500
005			20250512140611.0
264		0	_c19720524
008			197205s 0 0 eng d
022			_a0003-9780
040			_aNLM _beng _cNLM
100	1		_aFerko, A P
245	0	0	_aSome cardiac effects of 1-allyl-2-benzyl-piperidine hc1, in vitro and in vivo. _h[electronic resource]
260			_bArchives internationales de pharmacodynamie et de therapie _cApr 1972
300			_a363-75 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAlkenes _xpharmacology
650	0	4	_aAllyl Compounds _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnti-Arrhythmia Agents _xpharmacology
650	0	4	_aAnura
650	0	4	_aBenzyl Compounds _xpharmacology
650	0	4	_aCalcium Chloride _xantagonists & inhibitors
650	0	4	_aDepression, Chemical
650	0	4	_aDrug Antagonism
650	0	4	_aGuinea Pigs
650	0	4	_aHeart _xdrug effects
650	0	4	_aHeart Atria
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aIn Vitro Techniques
650	0	4	_aIsoproterenol _xantagonists & inhibitors
650	0	4	_aLethal Dose 50
650	0	4	_aLidocaine _xpharmacology
650	0	4	_aNeuromuscular Junction _xdrug effects
650	0	4	_aNorepinephrine _xantagonists & inhibitors
650	0	4	_aOuabain _xantagonists & inhibitors
650	0	4	_aPiperidines _xpharmacology
650	0	4	_aSciatic Nerve
650	0	4	_aVentricular Fibrillation _xchemically induced
773	0		_tArchives internationales de pharmacodynamie et de therapie _gvol. 196 _gno. 2 _gp. 363-75
999			_c5014926 _d5014926